10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
22.68
+0.63 (2.86%)
Jan 21, 2026, 4:00 PM EST - Market closed
10x Genomics Market Cap
10x Genomics has a market cap or net worth of $2.87 billion as of January 21, 2026. Its market cap has increased by 51.99% in one year.
Market Cap
2.87B
Enterprise Value
2.48B
1-Year Change
51.99%
Ranking
Category
Stock Price
$22.68
Market Cap Chart
Since September 12, 2019, 10x Genomics's market cap has decreased from $4.95B to $2.87B, a decrease of -42.02%. That is a compound annual growth rate of -8.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 2.87B | 39.06% |
| Dec 31, 2025 | 2.06B | 18.74% |
| Dec 31, 2024 | 1.74B | -73.72% |
| Dec 29, 2023 | 6.61B | 58.59% |
| Dec 30, 2022 | 4.17B | -74.93% |
| Dec 31, 2021 | 16.64B | 9.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BrightSpring Health Services | 8.00B |
| Doximity | 7.74B |
| HealthEquity | 7.18B |
| Waystar Holding | 5.69B |
| Hinge Health | 3.28B |
| HeartFlow | 2.91B |
| Privia Health Group | 2.85B |
| Omnicell | 2.20B |